Reata Soars On Positive Drug Trial Results

Reata soars on positive drug trial results

CNBC Television

Reata CEO on positive trial results for drug to treat Friedreich's ataxia

CNBC Television

Biogen soars on promising results from Alzheimer's drug trial

CNBC Television

Biogen shares drop despite positive Alzheimer's drug results

CNBC Television

Biogen to buy rare-disease drugmaker Reata in $7.3B deal

Alzheimer’s drug trial results hailed as ‘revolutionary

Biogen alzheimer's drug shows positive results

CNBC Television

Biogen and Eisai to reveal results of Alzheimer's drug trial

CNBC Television

Regeneron stock surges on positive results in eye disease drug trial

Biogen stock soars on promising data from Alzheimer’s drug trial

The quality of your clinical data drives everything, says Reata Pharma CEO Warren Huff

CNBC Television

Alzheimer drug trial results change 'landscape,' doctor says

NASDAQ: $UNCY 😃 Pivotal For The People: An Exciting Clinical Trial & An Interview With UNCY's EVP!

Benzinga Partner Studio

Novo Nordisk Shares Plummet 22% Following Disappointing Obesity Drug Trial Results

Eisai CEO on Alzheimer's treatment drug trial results

CNBC Television

38% & 46% Stock Loss RETA Stock News Reata Pharmaceuticals Health Lawsuit Securities Class Action

Levi & Korsinsky LLP

Eli Lilly stock soars following data suggesting its Alzheimer's drug can slow illness

Breaking News: CEO Reveals Stunning Results in Alzheimer's & Parkinson's Drug Trial

Proactive Investors

New hope as Alzheimer’s drug slows memory decline in phase 3 trial

AlzheimersResearch UK

Novo Nordisk stock plunges on obesity shot trial results